shr-a1811
mAbexperimentalADC
Clinical trial activity
65 trials · 19 clinical orgs · 0 marketing orgs
Phase 1
20
Phase 2
59
Phase 3
12
Phase 4
0
Earliest trial started Sep 3, 2020 (NCT04446260)
Timeline
Indications
Studied for
- Biliary Tract Neoplasms · Phase 2
- Brain Neoplasms · Phase 1/Phase 2
- Breast Neoplasms · Phase 3
- Carcinoma, Non-Small-Cell Lung · Phase 1/Phase 2
- Colorectal Neoplasms · Phase 3
- Drugs, Investigational · Phase 2
- Esophageal Neoplasms · Phase 3
- Lung Neoplasms · Phase 3
- Lymphoma, T-Cell · Phase 1
- Lymphoma, T-Cell, Cutaneous · Phase 1
- Neoplasm Metastasis · Phase 1/Phase 2
- Neoplasms · Phase 2
- Ovarian Neoplasms · Phase 3
- Pancreatic Neoplasms · Phase 2
- Salivary Gland Neoplasms · Phase 2
- Stomach Neoplasms · Phase 2
- Triple Negative Breast Neoplasms · Phase 2
- Urogenital Neoplasms · Phase 2
- Uterine Cervical Neoplasms · Phase 2
Mechanism of action
ERBB2 inhibitor
Chemistry & pharmacology
- Multi-specific
- No
- Payload
- Unclear
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07281209 | Phase 2 | Dec 31, 2025 | Jiao Tong University |
| NCT07275242 | Phase 1 | Dec 31, 2025 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
| NCT07307287 | Phase 2 | Dec 20, 2025 | Tianjin Medical University |
| NCT07309770 | Phase 2 | Dec 18, 2025 | Fudan University |
| NCT07129187 | Phase 2 | Oct 31, 2025 | Fujian Medical University |
| NCT07196774 | Phase 3 | Oct 23, 2025 | Hengrui Therapeutics, Inc. |
| NCT07051486 | Phase 2 | Oct 11, 2025 | Hengrui Therapeutics, Inc. |
| NCT07177950 | Phase 1/Phase 2 (Phase 2) | Sep 30, 2025 | Capital Medical University, Peking University |
| NCT07111832 | Phase 3 | Sep 30, 2025 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
| NCT07102901 | Phase 2 | Sep 5, 2025 | Hengrui Therapeutics, Inc. |
| NCT07132242 | Phase 2 | Aug 30, 2025 | Cancer Hospital of Yunnan provinceal, Chinese Academy of Medical Sciences |
| NCT07118527 | Phase 3 | Aug 18, 2025 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
| NCT07047443 | Phase 2 | Aug 1, 2025 | Anhui Medical University |
| NCT07037199 | Phase 2 | Jun 20, 2025 | Sun Yat-Sen University |
| NCT06990503 | Phase 3 | Jun 1, 2025 | Huazhong University of Science and Technology |
| NCT06975462 | Phase 2 | Jun 1, 2025 | Huazhong University of Science and Technology |
| NCT06990516 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2025 | Huazhong University of Science and Technology |
| NCT06975475 | Phase 2 | Jun 1, 2025 | Huazhong University of Science and Technology |
| NCT06881017 | Phase 2 | May 1, 2025 | China Medical University |
| NCT06927180 | Phase 2 | Apr 16, 2025 | Henan Medical University |
Showing 20 of 65 trials
Page 1 / 4
Organizations
Research & Development (19)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hengrui Therapeutics, Inc. | For profit | 24 | 20 | 3 | 2020 |
| Suzhou Suncadia Biopharmaceuticals Co., Ltd. | For profit | 12 | 12 | 3 | 2022 |
| Fudan University | Academic/Hospital | 9 | 9 | 1 | 2022 |
| Huazhong University of Science and Technology | Academic/Hospital | 5 | 5 | 2 | 2024 |
| Henan Medical University | Academic/Hospital | 4 | 4 | 1 | 2023 |
| China Medical University | Academic/Hospital | 2 | 2 | 1 | 2024 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 2 | 2 | 1 | 2024 |
| Shengjing Hospital | Academic/Hospital | 2 | 2 | 1 | 2022 |
| Simcere Pharmaceutical Co., Ltd | For profit | 2 | 2 | 1 | 2022 |
| Sun Yat-Sen University | Academic/Hospital | 2 | 1 | 2 | 2022 |
| Anhui Medical University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Atridia Pty Ltd. | For profit | 1 | 0 | 1 | 2020 |
| Cancer Hospital of Yunnan provinceal | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Capital Medical University | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Fujian Medical University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Government of China | Government | 1 | 1 | 1 | 2024 |
| Jiao Tong University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Peking University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Tianjin Medical University | Academic/Hospital | 1 | 1 | 1 | 2025 |
19 organizations
Page 1 / 1